mevastatin has been researched along with Lung Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, W; He, M; Jiang, X; Li, B; Liao, S; Lin, C; Liu, Y; Miao, J; Mo, Z; Qin, Z; Tang, H; Wei, Q; Xie, T; Xu, J | 1 |
| Corey, DA; Kelley, TJ; Kraynack, NC; Kreiselmeier, NE | 1 |
| Kenna, T; Mattarollo, SR; Nicol, AJ; Nieda, M | 1 |
| Clynes, M; Eustace, AJ; Glynn, SA; O'Donovan, N; O'Sullivan, D | 1 |
| Bennis, F; Favre, G; Le Gaillard, F; Soula, G | 1 |
5 other study(ies) available for mevastatin and Lung Neoplasms
| Article | Year |
|---|---|
A new insight of immunosuppressive microenvironment in osteosarcoma lung metastasis.
Topics: Bone Neoplasms; CD8-Positive T-Lymphocytes; Endothelial Cells; Humans; Immunosuppressive Agents; Lung Neoplasms; Osteosarcoma; Tumor Microenvironment | 2023 |
Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Anticholesteremic Agents; Cell Line, Tumor; Cholesterol; Cystic Fibrosis; DNA-Binding Proteins; Gene Expression Regulation, Enzymologic; Humans; Lovastatin; Lung Neoplasms; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Protein Inhibitors of Activated STAT; Proteins; Respiratory Mucosa; rhoA GTP-Binding Protein; Signal Transduction; STAT1 Transcription Factor; Terpenes; Trans-Activators | 2003 |
Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Burkitt Lymphoma; Carcinoma; Cell Line, Tumor; Cisplatin; Colorectal Neoplasms; Concanavalin A; Cytotoxicity, Immunologic; Diphosphonates; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Genes, T-Cell Receptor delta; Genes, T-Cell Receptor gamma; Humans; Imidazoles; Interferon-gamma; Lovastatin; Lung Neoplasms; Male; Membrane Glycoproteins; Neoplasms; Perforin; Pore Forming Cytotoxic Proteins; Prostatic Neoplasms; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Urinary Bladder Neoplasms; Vincristine; Zoledronic Acid | 2007 |
The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells.
Topics: Apoptosis; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Lovastatin; Lung Neoplasms; Male; Melanoma; Neoplasm Invasiveness; Simvastatin; Skin Neoplasms | 2008 |
Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549.
Topics: Adenocarcinoma; Cholesterol, LDL; Feedback; Humans; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Lovastatin; Lung Neoplasms; Mevalonic Acid | 1993 |